抗菌药物耐药与同一健康:弗莱明基金的治理与实施经验
本文反思弗莱明基金在25个国家设计实施同一健康抗菌药物耐药项目的经验,提炼未来项目设计教训;强调同一健康应作为问题框定与行动方法而非项目产出,需持续投入动物与环境部门,监测应兼顾部门角色与需求并支持联合解读,多部门协调成本应明确资源化。
要点
- 同一健康应视为问题框定与行动方法,而非项目产出。
- 有意义的实施需超越人类健康,持续投入动物与环境部门。
- 监测系统应兼顾部门角色与需求,支持联合解读证据。
核心结论
- 同一健康应作为问题框定与行动方法而非项目产出,并允许各国灵活调整。
- 有意义的实施需超越人类健康持续投入,尤其动物与环境部门,避免象征性参与。
- 多部门协调成本应明确资源化,正式治理机制与非正式专业网络均对建立信任、维持合作和将数据转化为政策行动至关重要。
研究设计与样本
- 本文为经验反思类文章,基于弗莱明基金在25个国家设计实施同一健康抗菌药物耐药项目的经验。
主要发现
- 弗莱明基金经验突出在抗菌药物耐药项目中有效实施同一健康的关键优先事项。
- 许多见解也适用于新发传染病与健康安全等其他情境。
- 监测系统应考虑部门角色与部门特定需求,并支持联合解读与使用证据的能力。
临床怎么用
- 将同一健康作为问题框定与行动方法,允许国家灵活调整。
- 持续投入动物与环境部门,避免象征性参与。
- 监测设计兼顾部门角色与需求,支持联合解读证据。
- 明确资源化多部门协调成本,认可正式治理机制与非正式专业网络。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This paper reflects upon the experience of the Fleming Fund in designing and implementing One Health antimicrobial resistance (AMR) programs in 25 countries and identifies practical lessons for the design of future One Health programs. The Fleming Fund experience highlights key priorities for implementing One Health effectively within AMR programs-though many of the insights should be applicable to other contexts as well, such as emerging infectious diseases and health security. One Health should be treated as an approach to problem framing and action rather than a program output, with flexibility for national adaptation. Meaningful implementation requires sustained investment beyond human health, particularly in animal and environmental sectors, to avoid symbolic engagement. Surveillance systems should consider both the role of the sector and sector-specific needs, supported by capacity for joint interpretation and use of evidence. The costs of multisectoral coordination should be explicitly resourced and both formal governance mechanisms and informal professional networks recognized as essential for building trust, sustaining collaboration, and translating data into policy-relevant action.
引用
- Abbas SS, Maudling R, Andremont A, et al. Antimicrobial Resistance and One Health: Lessons on One Health Governance and Implementation from the Fleming Fund. Clin Infect Dis. 2026. PMID: 42895837. doi:10.1093/cid/ciag517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。